Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > Uncategorized > Draft Guideline for Lot Release of Human Vaccines, Blood Products (Plasma Derivatives Medicinal Products) and Anti-Sera (Edition 03)

Draft Guideline for Lot Release of Human Vaccines, Blood Products (Plasma Derivatives Medicinal Products) and Anti-Sera (Edition 03)

Abdul Qadir Uncategorized November 13, 2025November 13, 2025

document-4 Download

Share this:

Twitter
Facebook

← Decisions of the 105th Meeting of the Medical Device Board (MDB) held on 23-10-2025 (Manual Applications)
Training on Software for Electronic Submission of Applications for Quota Allocations and Functions of Controlled Drugs Division →

Archives

Meta

Log in

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem